2500 — Venus Medtech (Hangzhou) Share News
0.000.00%
Last trade - 00:00- HK$476.29m
- HK$630.40m
- CNY306.79m
Brief: Venus Medtech Hangzhou Says Haiyue Ma Resigned As Chief Financial Officer
Brief: Venus Medtech Hangzhou Posts FY Loss Attributable RMB1.06 Bln
Brief: Venus Medtech Hangzhou Says Hangzhou Broncus Medical, Unit, Among Others Enters Partnership Agreement
Brief: Venus Medtech Hangzhou Says Lim Hou-Sen Resigns As An Executive Director
Brief: Venus Medtech Hangzhou Posts HY Loss Attributable RMB199.9 Million
Brief: Venus Medtech Hangzhou Says Transcatheter Pulmonic Valve Replacement Received Approval Of NMPA Of PRC
Brief: GIC Private Ltd's Long Position In H-Share Of Venus Medtech Falls To 4.99% - Filing
Brief: GIC Private Limited's Long Position In H-Share Of Venus Medtech Falls To 5.85% - HKEX Filing
Brief: Venus Medtech Hangzhou Says On April 8, Venusp-Valve Received CE Marking Under Medical Devices Regulation & Marketed In Europe
Brief: GIC Private Limited's Long Position In H-Share Of Venus Medtech Falls To 6.97% - Filing
Brief: Venus Medtech Hangzhou Proposed To Re-Elect Min Frank Zeng, Zhenjun Zi And Lim Hou-Sen As Executive Directors
Brief: Venus Medtech Hangzhou Posts FY Loss Attributable Rmb373.6 Million
Brief: GIC's Long Position In Venus Medtech Hangzhou Falls To 7.99% - HKEx Filing
China's Venus Medtech jumps on completion of first-in-man clinical trial of product
Venus Medtech jumps most in 15 months on Cardiovalve acquisition
Brief: Venus Medtech Hangzhou Says Athena Medtech To Buy Mitraltech
Brief: Venus Medtech Hangzhou To Repurchase A Number Of H Shares Of Co
Brief: Venus Medtech Hangzhou Entered Into A Agreement With United Family Healthcare
Venus MedTech leads slide in HK-listed medical devices, pharmaceutical segment